Fundraising Fox

Morphoceuticals

Medford, US · Founded 2020 · Delaware corporation · 1 known investors

Founders & leadership

MR
Michael R. HuffordDirector
JJ
James JensonExecutive Officer, Director
DG
David GillExecutive Officer
AK
Amy KruseDirector
AP
Alexander PickettDirector
JB
Justin BriggsDirector
TH
Tamim Hamad J.J Al-ThaniDirector
RH
Rosemarie HunzikerDirector

Investors · 1

Reported raises · per SEC filings

Form D private placements
$3.5MraisedOct 2024 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael R. HuffordDirector
  • Alexander PickettDirector
  • Justin BriggsDirector
  • Tamim Hamad J.J Al-ThaniDirector
  • Rosemarie HunzikerDirector
  • James JensonExecutive Officer, Director
Offering amount
$5.5M
Amount sold
$3.5M
First sale
Sep 2024
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$9.8MraisedJan 2023 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Alexander PickettDirector
  • Michael LevinPromoter
  • David GillExecutive Officer
  • David KaplanPromoter
  • Amy KruseDirector
  • Michael R. HuffordExecutive Officer, Director
  • Rosemarie HunzikerDirector
Offering amount
$9.8M
Amount sold
$9.8M
Proceeds to insiders
$612K
First sale
Jan 2023
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.